Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: June 09, 2016
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
Journal: Drug, healthcare and patient safety
Published: January 01, 2016
Incremental direct and indirect costs of untreated vasomotor symptoms.
Journal: Menopause (New York, N.Y.)
Published: February 26, 2015
Showing 1-3 of 3
Last Updated: 09/26/2026